Bruker holder plans sale of 3,473 shares

Bruker Corporation has a holder planning to sell 3,473 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $197,613.70, to be sold on or after August 17, 2026 on NASDAQ.

Rhea-AI Filing Summary

Bruker Corporation has a holder planning to sell 3,473 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $197,613.70, to be sold on or after August 17, 2026 on NASDAQ.

The same holder reports prior sales of restricted common stock back to the issuer in the past three months, including 847 shares on August 9, 2026, 565 shares on August 10, 2026, 605 shares on August 11, 2026, and 1,456 shares on August 15, 2026.

Key Figures

Shares proposed to be sold: 3,473 shares Aggregate market value of proposed sale: $197,613.70 Proposed sale date: 08/17/2026 +4 more

7 metrics

Shares proposed to be sold 3,473 shares Common stock to be sold through Morgan Stanley Smith Barney LLC

Aggregate market value of proposed sale $197,613.70 Total market value for 3,473 shares of common stock

Proposed sale date 08/17/2026 Date on or after which common shares may be sold on NASDAQ

Shares sold 08/09/2026 847 shares Restricted common stock sold to issuer in past 3 months

Shares sold 08/10/2026 565 shares Restricted common stock sold to issuer in past 3 months

Shares sold 08/11/2026 605 shares Restricted common stock sold to issuer in past 3 months

Shares sold 08/15/2026 1,456 shares Restricted common stock sold to issuer in past 3 months

Key Terms

Form 144, restricted stock, aggregate market value, issuer

4 terms

Form 144 regulatory

"144: Securities Information Common | Morgan Stanley Smith Barney LLC"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock financial

"Common | 08/09/2026 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

aggregate market value financial

"3473 | 197613.70 | 152359316 | 08/17/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

issuer regulatory

"Restricted Stock | Issuer | | | 847 | 08/09/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for BRKR disclose about planned share sales?

The filing discloses a plan to sell 3,473 shares of Bruker common stock with an aggregate market value of $197,613.70. The sale is to be executed through Morgan Stanley Smith Barney LLC on or after August 17, 2026 on NASDAQ.

How many BRKR shares are planned to be sold and at what value?

The reporting holder plans to sell 3,473 common shares of BRKR with an aggregate market value of $197,613.70. This amount reflects the total value of the planned sale as reported, not the current market capitalization of Bruker.

Which broker is handling the planned BRKR share sale in this Form 144?

The planned sale of BRKR shares is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The shares are slated for sale on or after August 17, 2026 on NASDAQ, according to the Form 144 disclosure.

What BRKR restricted stock sales were made in the past three months?

The holder reports selling restricted BRKR common stock back to the issuer: 847 shares on August 9, 2026, 565 shares on August 10, 2026, 605 shares on August 11, 2026, and 1,456 shares on August 15, 2026, all classified as restricted stock.

Are the BRKR shares in the Form 144 filing classified as restricted stock?

Yes. The transactions listed for the past three months describe the BRKR shares as restricted stock sold to the issuer. The planned sale section covers common stock generally, with the detailed category noted as restricted in the recent transactions table.

On which market will the planned BRKR Form 144 sale occur?

The planned sale of BRKR common stock is reported to take place on NASDAQ. The filing lists the proposed sale date as on or after August 17, 2026, with 3,473 shares and $197,613.70 aggregate market value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:07 PM Accepted by SEC EDGAR 08/17/2026 - 04:07 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002143997
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bruker Corporation
SEC File Number	001-42828
Address of Issuer	40 Manning Road Billerica, MASSACHUSETTS 01821
Phone	978-663-3660
Name of Person for Whose Account the Securities are To Be Sold	WOLFGANG PUSCH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3473	197613.70	152359316	08/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/09/2026	Restricted Stock	Issuer			847	08/09/2026	Not Applicable
Common	08/10/2026	Restricted Stock	Issuer			565	08/10/2026	Not Applicable
Common	08/11/2026	Restricted Stock	Issuer			605	08/11/2026	Not Applicable
Common	08/15/2026	Restricted Stock	Issuer			1456	08/15/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Wolfgang Pusch
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)